WHO Letter Blasts Cadila on Data Integrity Concerns and GMP Issues

Shortly after receiving an FDA warning letter for alleged major quality deficiencies, an Indian vaccine maker was slammed for data integrity issues and GMP violations by the World Health Organization.
Source: Drug GMP Report